These results exhibited that THBS2 had a remarkable positive correlation with the drug AUC in BRCA, CRC, HNSC, and STAD, suggesting THBS2 could serve as a biomarker for chemoresistance (Fig. 2O). Here, THBS2 is linked to colorectal carcinoma.